Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Urgent.ly Inc.
13G/A
Amendment 1
ULYX · 916931207
|
0% |
7/6/2026
Event 6/30/2026
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Urgent.ly Inc.
13G
ULYX · 916931207
|
9.1% |
3/23/2026
Event 3/16/2026
|
|||
| Beryl Capital Management LLC | 9.1% | ||||
| Beryl Capital Management LP | 9.1% | ||||
| Beryl Capital Partners II LP | 6.8% | ||||
| David A. Witkin | 9.1% | ||||
|
Y-mAbs Therapeutics, Inc.
13G/A
Amendment 1
YMAB · 984241109
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Vigil Neuroscience, Inc.
13G/A
Amendment 1
VIGL · 92673K108
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Streamline Health Solutions Inc.
13G/A
Amendment 1
STRM · 86323X205
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Sigmatron International Inc
13G/A
Amendment 1
SGMA · 82661L101
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Enzo Biochem Inc
13G/A
Amendment 1
ENZB · 294100102
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
DallasNews Corp
13G/A
Amendment 1
DALN · 235050101
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
2seventy bio, Inc.
13G/A
Amendment 1
TSVT · 901384107
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
PHX Minerals Inc.
13G/A
Amendment 1
PHX · 69291A100
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Nevro Corp
13G/A
Amendment 1
NVRO · 64157F103
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Inozyme Pharma, Inc.
13G/A
Amendment 1
INZY · 45790W108
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Checkpoint Therapeutics, Inc.
13G/A
Amendment 1
CKPT · 162828206
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Allakos Inc.
13G/A
Amendment 1
ALLK · 01671P100
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Y-mAbs Therapeutics, Inc.
13G
YMAB · 984241109
|
9.0% |
8/12/2025
Event 8/5/2025
|
|||
| Beryl Capital Management LLC | 9.0% | ||||
| Beryl Capital Management LP | 9.0% | ||||
| Beryl Capital Partners II LP | 6.8% | ||||
| David A. Witkin | 9.0% | ||||
|
DallasNews Corp
13G
DALN · 235050101
|
9.9% |
7/22/2025
Event 7/15/2025
|
|||
| Beryl Capital Management LLC | 9.9% | ||||
| Beryl Capital Management LP | 9.9% | ||||
| Beryl Capital Partners II LP | 7.5% | ||||
| David A. Witkin | 9.9% | ||||
|
Enzo Biochem Inc
13G
ENZB · 294100102
|
9.7% |
7/1/2025
Event 6/24/2025
|
|||
| Beryl Capital Management LLC | 9.7% | ||||
| Beryl Capital Management LP | 9.7% | ||||
| Beryl Capital Partners II LP | 7.8% | ||||
| David A. Witkin | 9.7% | ||||
|
Streamline Health Solutions Inc.
13G
STRM · 86323X205
|
8.6% |
6/5/2025
Event 5/29/2025
|
|||
| Beryl Capital Management LLC | 8.6% | ||||
| Beryl Capital Management LP | 8.6% | ||||
| Beryl Capital Partners II LP | 7.0% | ||||
| David A. Witkin | 8.6% | ||||
|
Vigil Neuroscience, Inc.
13G
VIGL · 92673K108
|
9.9% |
5/30/2025
Event 5/22/2025
|
|||
| Beryl Capital Management LLC | 9.9% | ||||
| Beryl Capital Management LP | 9.9% | ||||
| Beryl Capital Partners II LP | 8.0% | ||||
| David A. Witkin | 9.9% | ||||
|
Sigmatron International Inc
13G
SGMA · 82661L101
|
9.7% |
5/29/2025
Event 5/21/2025
|
|||
| Beryl Capital Management LLC | 9.7% | ||||
| Beryl Capital Management LP | 9.7% | ||||
| Beryl Capital Partners II LP | 7.8% | ||||
| David A. Witkin | 9.7% | ||||
|
PHX Minerals Inc.
13G
PHX · 69291A100
|
8.9% |
5/27/2025
Event 5/19/2025
|
|||
| Beryl Capital Management LLC | 8.9% | ||||
| Beryl Capital Management LP | 8.9% | ||||
| Beryl Capital Partners II LP | 7.1% | ||||
| David A. Witkin | 8.9% | ||||
|
Inozyme Pharma, Inc.
13G
INZY · 45790W108
|
9.8% |
5/23/2025
Event 5/16/2025
|
|||
| Beryl Capital Management LLC | 9.8% | ||||
| Beryl Capital Management LP | 9.8% | ||||
| Beryl Capital Partners II LP | 7.9% | ||||
| David A. Witkin | 9.8% | ||||
|
Stronghold Digital Mining, Inc.
13G/A
Amendment 3
SDIG · 86337R202
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Revance Therapeutics, Inc.
13G/A
Amendment 1
RVNC · 761330109
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Marinus Pharmaceuticals, Inc.
13G/A
Amendment 1
MRNS · 56854Q200
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Emcore Corp
13G/A
Amendment 1
EMKR · 290846401
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Core Scientific, Inc.
13G/A
Amendment 1
CORZ · 21874A106
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Brightcove Inc
13G/A
Amendment 1
BCOV · 10921T101
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Beryl Capital Management LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Allakos Inc.
13G
ALLK · 01671P100
|
8.9% |
4/9/2025
Event 4/2/2025
|
|||
| Beryl Capital Management LLC | 8.9% | ||||
| Beryl Capital Management LP | 8.9% | ||||
| Beryl Capital Partners II LP | 7.2% | ||||
| David A. Witkin | 8.9% | ||||
|
2seventy bio, Inc.
13G
TSVT · 901384107
|
8.1% |
3/18/2025
Event 3/11/2025
|
|||
| Beryl Capital Management LLC | 8.1% | ||||
| Beryl Capital Management LP | 8.1% | ||||
| Beryl Capital Partners II LP | 6.6% | ||||
| David A. Witkin | 8.1% | ||||
|
Checkpoint Therapeutics, Inc.
13G
CKPT · 162828206
|
9.9% |
3/17/2025
Event 3/10/2025
|
|||
| Beryl Capital Management LLC | 9.9% | ||||
| Beryl Capital Management LP | 9.9% | ||||
| Beryl Capital Partners II LP | 8.0% | ||||
| David A. Witkin | 9.9% | ||||
|
Nevro Corp
13G
NVRO · 64157F103
|
6.5% |
3/10/2025
Event 3/3/2025
|
|||
| Beryl Capital Management LLC | 6.5% | ||||
| Beryl Capital Management LP | 6.5% | ||||
| Beryl Capital Partners II LP | 5.3% | ||||
| David A. Witkin | 6.5% | ||||
|
Seaport Entertainment Group Inc.
13G/A
Amendment 1
SEG · 812215200
|
2.7% |
2/13/2025
Event 12/31/2024
|
|||
| Beryl Capital Management LLC | 2.7% | ||||
| Beryl Capital Management LP | 2.7% | ||||
| Beryl Capital Partners II LP | 2.3% | ||||
| David A. Witkin | 2.7% | ||||
|
Profire Energy Inc
13G/A
Amendment 1
PFIE · 74316X101
|
0% |
2/13/2025
Event 12/31/2024
|
|||
| Beryl Capital Management, LLC | 0% | ||||
| Beryl Capital Management LP | 0% | ||||
| Beryl Capital Partners II LP | 0% | ||||
| David A. Witkin | 0% | ||||
|
Surmodics Inc
13G/A
Amendment 1
SRDX · 868873100
|
1.7% |
2/13/2025
Event 12/31/2024
|
|||
| Beryl Capital Management LLC | 1.7% | ||||
| Beryl Capital Management LP | 1.7% | ||||
| Beryl Capital Partners II LP | 1.4% | ||||
| David A. Witkin | 1.7% | ||||
|
Stronghold Digital Mining, Inc.
13G/A
Amendment 2
SDIG · 86337R202
|
6.2% |
2/5/2025
Event 12/31/2024
|
|||
| Beryl Capital Management LLC | 6.2% | ||||
| Beryl Capital Management LP | 6.2% | ||||
| Beryl Capital Partners II LP | 5.4% | ||||
| David A. Witkin | 6.2% | ||||
|
Revance Therapeutics, Inc.
13G
RVNC · 761330109
|
6.1% |
1/10/2025
Event 1/2/2025
|
|||
| Beryl Capital Management LLC | 6.1% | ||||
| Beryl Capital Management LP | 6.1% | ||||
| Beryl Capital Partners II LP | 5.3% | ||||
| David A. Witkin | 6.1% | ||||
|
Marinus Pharmaceuticals, Inc.
13G
MRNS · 56854Q200
|
9.9% |
1/7/2025
Event 12/30/2024
|
|||
| Beryl Capital Management LLC | 9.9% | ||||
| Beryl Capital Management LP | 9.9% | ||||
| Beryl Capital Partners II LP | 8.7% | ||||
| David A. Witkin | 9.9% | ||||